| scholarly article | Q13442814 |
| P50 | author | Mary A. Whooley | Q56332432 |
| Michael G Shlipak | Q87224063 | ||
| Eric Vittinghoff | Q37323613 | ||
| P2093 | author name string | Peter Ganz | |
| Carmen A Peralta | |||
| Meyeon Park | |||
| P2860 | cites work | Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease – a cross-sectional study of predialysis, dialysis and kidney-transplantation patients | Q61853243 |
| Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes | Q61927901 | ||
| Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction | Q72726614 | ||
| Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi | Q79267289 | ||
| A transmembrane tight junction protein selectively expressed on endothelial cells and platelets | Q28201696 | ||
| Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization | Q28283679 | ||
| Aptamer-based multiplexed proteomic technology for biomarker discovery | Q28744329 | ||
| Testing endothelial vasomotor function: nitric oxide, a multipotent molecule | Q33973467 | ||
| Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
| Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes | Q34751855 | ||
| Population-based risk assessment of APOL1 on renal disease. | Q35595514 | ||
| Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease | Q35918683 | ||
| Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction. | Q36109189 | ||
| The assessment of endothelial function: from research into clinical practice | Q36190146 | ||
| Chronic kidney disease: effects on the cardiovascular system | Q36868237 | ||
| Clinical and subclinical cardiovascular disease and kidney function decline in the elderly | Q37228758 | ||
| Differential associations between soluble cellular adhesion molecules and atherosclerosis in the Dallas Heart Study: a distinct role for soluble endothelial cell-selective adhesion molecule | Q37407759 | ||
| Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association? | Q37986290 | ||
| Endothelial cell-selective adhesion molecule modulates atherosclerosis through plaque angiogenesis and monocyte-endothelial interaction | Q39712763 | ||
| Endothelial cell-selective adhesion molecule regulates albuminuria in diabetic nephropathy | Q39867884 | ||
| Systemic nature of endothelial dysfunction in atherosclerosis | Q40598028 | ||
| Low serum endothelial cell-selective adhesion molecule predicts increase in albuminuria in type 2 diabetes patients | Q44498938 | ||
| Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease | Q44948995 | ||
| Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. | Q45124614 | ||
| Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study | Q46871134 | ||
| Cardiovascular disease and subsequent kidney disease | Q50155784 | ||
| Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study. | Q51792022 | ||
| Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). | Q53150011 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| coronary artery disease | Q844935 | ||
| biomarker | Q864574 | ||
| P304 | page(s) | 231-236 | |
| P577 | publication date | 2013-10-31 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Role of soluble endothelial cell-selective adhesion molecule biomarker in albuminuria and kidney function changes in patients with coronary artery disease: the Heart and Soul Study | |
| P478 | volume | 34 |
| Q41960243 | Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute ST-segment elevation myocardial infarction: results of the HORIZONS-AMI trial |
| Q36120546 | Glomerular filtration rate (GFR) during and after STEMI: a single-centre, methodological study comparing estimated and measured GFR |
| Q36328272 | Soluble endothelial cell selective adhesion molecule and cardiovascular outcomes in patients with stable coronary disease: A report from the Heart and Soul Study |
Search more.